Blog
RSS FeedPosted by Michael Wonder on 31 Aug 2021
Price relief as epilepsy drug PBS listed
1 September 2021 - Australian epilepsy sufferers will now be reimbursed for a drug that reduces uncontrolled seizures, as a ...
Posted by Michael Wonder on 31 Aug 2021
Schedule of Pharmaceutical Benefits - 1 September 2021 update
1 September 2021 - The September 2021 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 30 Aug 2021
Public Summary Documents – May 2021 PBAC meeting
27 August 2021 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the May 2021 PBAC ...
Posted by Michael Wonder on 29 Aug 2021
Breakthrough PBS listings to benefit thousands of Australians
29 August 2021 - From 1 September 2021, thousands of Australians living with schizophrenia, liver disease, lymphoma and anaphylaxis will have ...
Posted by Michael Wonder on 24 Aug 2021
Limited access to 'lifesaving' cystic fibrosis drug Trikafta under Pharmaceutical Benefits Scheme
24 August 2021 - A mother whose son lives with cystic fibrosis says young people are dying as they wait for ...
Posted by Michael Wonder on 20 Aug 2021
Recommendations made by the PBAC – July 2021
20 August 2021 - Recommendations made by the PBAC in July 2021 relating to the listing of medicines on the PBS ...
Posted by Michael Wonder on 17 Aug 2021
Final terms of reference and public consultation to the post-market review of opiate dependence treatment program medicines
17 August 2021 - The public consultation process for the post-market review of opiate dependence treatment program medicines is now ...
Posted by Michael Wonder on 13 Aug 2021
PBS arrangements for tocilizumab shortage
13 August 2021 - The sponsor of tocilizumab (Actemra) Roche has notified the TGA of shortages of multiple presentations of tocilizumab ...
Posted by Michael Wonder on 12 Aug 2021
Drug shortages putting patients at risk
12 August 2021 - Pharmacists are reporting critical shortages in heart and stroke medications, mental health drugs and HRT therapies ...
Posted by Michael Wonder on 09 Aug 2021
Version 4 and counting
9 August 2021 - The Department of Health has published yet another revised agenda for the November 2021 PBAC meeting. ...
Posted by Michael Wonder on 06 Aug 2021
Updated financial estimates workbook
6 August 2021 - An updated version of the Utilisation and Cost Model workbook is now available to support PBAC submissions. ...
Posted by Michael Wonder on 03 Aug 2021
DoH publishes revised agenda for Nov 2021 PBAC meeting
3 August 2021 - One week on and we are already up to version 3. ...
Posted by Michael Wonder on 03 Aug 2021
National Medicines Policy Review Committee and Terms of Reference
3 August 2021 - The National Medicines Policy has influenced a number of important strategies, frameworks and programs developed since ...
Posted by Michael Wonder on 02 Aug 2021
Government subsidises medicine to combat high cholesterol in ‘high-risk’ Australians
1 August 2021 - Experts are welcoming the PBS listing of a medicine that helps reduce unacceptably high ‘bad cholesterol’ ...
Posted by Michael Wonder on 02 Aug 2021
National Medicines Policy Review will be significant for all Australians
30 July 2021 - Medicines Australia is eager to be part of a significant moment in history for Australian health ...